Eviden’s Post

Ana Govedarica, President of the Swiss-Serbian Chamber of Commerce (SSCC) Digitalisation, science and research are crucial to the SSCC’s work, because they are critical to the development of Serbia’s economy, healthcare and overall progress. Read full interview at the link - https://lnkd.in/dipvkyU8 #Switzerland #Switzerland2024 #economy #healthcare #cordmagazine #cord20years

The data from 2023 in the Israeli high-tech industry raise significant questions about the future of the economic growth engine. However, a nuanced analysis of the data may suggest that this crisis is more punctual rather than chronic. Nevertheless, we must ask ourselves what the next stage in the evolution of Israeli high-tech will be and concentrate national efforts toward achieving it. Dr. Esther Luzzatto, CEO of The Group, recommends that the government and the socio-economic cabinet also prioritize attention to the high-tech sector. She outlines six actions that can be taken to drive forward the most important growth engine of the Israeli economy. Read here>> https://bit.ly/3UmXPru #IsraeliHighTech #EconomicGrowth #TechIndustry #IsraeliEconomy

Declining Business Activity in Germany suggests a downturn in economic activity within the country, potentially indicating challenges or weaknesses in various sectors. To Know More, Visit: https://shorturl.at/yGOY5 #Businessinternationalnews #internationalnews #Businessnews   #germanydeclinebusinessnews #dailynews #germanyupdatenews #germany #breakingnews #globalnews #germanynews  #germanybusinessnews

🔔 Last Friday, Zepos & Yannopoulos published its 2023 Annual Report 📓. It includes my article on the trends surrounding the #lifesciences industry 💊.    🔊 “Digital health”, “#Healthcare Transformation”, “#AI”, “#ESG”, “Legislative Reform”: These were only a few of the headline issues we saw in 2023 in the life sciences industry, and they will surely continue to be invoked frequently during 2024 and the years to come. As the sector transitions through crucial legislative reform, while still under considerable financial pressure from various angles, incorporating innovative technologies and new business models into the existing modus operandi, and simultaneously adapting to new obligations and ESG requirements may be the biggest hurdle life sciences companies will face in 2024. Many stakeholders are trying to keep pace with an ever-changing environment, and determining which advancements to prioritise, and which to forego, can be a challenging task. Those who cannot keep up will be left behind, as 2024 is likely when industry players will set their course for the coming years.”   📋 Read the full article in the annual report available at https://bit.ly/43Mi0mW   ✨ Among others, you can read insights into #Greece’s business landscape, provided by representatives from key sectors of the Greek economy who share their thoughts on the opportunities and challenges, as well as the thoughts of fellow partners on the drivers and trends in their respective practices.

The culmination of thousands of data points, industry insight, and careful expert analysis, Allegiant’s International INGO Benefits Trend Report: 2024 Edition is the most comprehensive source of benchmarking information available. It also digs deep into how the changing global landscape has impacted INGOs and explores several emerging trends. Swipe to preview three of the trends and download the full report here:  https://lnkd.in/eqFJ2FFe #INGO #NGO #benefitstrends #trendreport #safetyandsecurity #healthinsurance #benefitequity #mentalhealthcare

Expanding into the U.S. market? Learn how to leverage industry insights, tailor strategies, and overcome challenges with Kettering International. Read our latest blog now! https://hubs.la/Q02wx1B20 #KetteringInternational #MarketExpansion #IndustryInsights #USConsumers #BusinessSuccess

Did you know that... 💥 R&D expenditure in Flanders is €10.8 BILLION? 💥 The region is NUMBER 1 in Europe for the proportion of enterprises with innovation activities? 💥 Flanders is the 3rd MOST INNOVATIVE ECONOMY in the whole world? 😯 The impressive figures come from the new version of STI in Flanders, published by the Department of Economy, Science and Innovation (Departement Economie, Wetenschap en Innovatie (EWI)). 📄 In English, there is a short version with the main points and a comprehensive overview on policies with more detailed figures. It covers the #research and #innovation landscape, including all the actors and stakeholders, access to #finance, spearhead #clusters (like MEDVIA) and much, much more. Download both versions FOR FREE ⬇ https://lnkd.in/dFynF6sv #STIinFlanders #science #economy #healthtech #healthinnovation

In their latest research, wudong Guo, Peimeng Wang, Xue Li, Yuzheng Zhang, Yaoling Wang, Kun Zhao, Francis Ruiz, Rui Li, Feiyi Xiao, Xuefei Gu, Mao You, and Qiang Fu delve into the evolution of health technology assessment (HTA) in China. The study details key milestones, the roles of various actors, the processes involved, and the context influencing HTA's trajectory. Despite facing numerous challenges, the authors report considerable advancements over the last thirty years, with promising prospects for HTA's future applications. Find their full article here: https://bit.ly/3RdLSUt Volume 9, issue 3, 2024 - Center for Global Development

The latest issue of the HTAi Review is here! 🎉 Dive into the freshest updates from our global #HTA community, mark your calendars with key dates, and get the scoop on our HTAi 2025 Annual Meeting webinar. Plus, don’t miss our recap of the HTAi Latin America Regional Meeting. Check it out now and stay in the loop! https://lnkd.in/g9YH7zyz #HTAiReview #HTACommunity #StayInformed

🗺️Ready to take your business to the next level? Discover the strategies and tips to navigate the US business landscape. 💼 Watch the panel discussion now and unlock the keys to sustainable growth. #USMarketExpansion #BusinessGrowth https://lnkd.in/eTrfsBdq